Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation - PubMed (original) (raw)
Comparative Study
doi: 10.1002/jmv.1013.
Affiliations
- PMID: 11285565
- DOI: 10.1002/jmv.1013
Comparative Study
Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation
C Y Tong et al. J Med Virol. 2001 May.
Abstract
Cytokines such as tumour necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) are thought to be important in the pathogenesis of post-transplant cytomegalovirus (CMV) disease. CMV infection increases the production of TNF-alpha and IL-6. Conversely, TNF-alpha switches on the replication of CMV. To study the association of these two cytokines with CMV activity and disease, TNF-alpha and IL-6 levels were assayed in plasma samples taken serially from three groups of renal transplant recipients. Group A (n = 12) had CMV disease and syndrome; Group B (n = 11) had detectable CMV DNA in plasma or peripheral blood leucocytes without disease, i.e., presumed asymptomatic CMV infection, and Group C (n = 11) had no detectable CMV DNA nor disease. The median peak TNF-alpha levels in patients with CMV disease (Group A) were significantly higher than that in Group B or Group C (P < 0.02) whereas the median peak IL-6 levels in group C patients were significantly lower than that in group A (P < 0.04) or group B (P < 0.03). A TNF-alpha level of above 100 pg/ml was significantly associated with CMV disease and high plasma CMV load (> 10,000 copies/ml). IL-6 levels above 15 pg/ml were significantly associated with CMV DNA detection, but not with CMV disease or elevated CMV load. High levels of TNF-alpha or IL-6 were not associated with CMV donor/recipient serostatus, HHV-6 or HHV-7 DNA detection, immunosuppressive regimen or rejection episodes. The role of TNF-alpha in the pathogenesis of CMV disease deserves further investigation.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
- Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients.
Tong CY, Bakran A, Williams H, Cheung CY, Peiris JS. Tong CY, et al. Transplantation. 2000 Jul 15;70(1):213-6. Transplantation. 2000. PMID: 10919606 Clinical Trial. - Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
Vu D, Shah T, Ansari J, Sakharkar P, Yasir Q, Naraghi R, Hutchinson I, Min D. Vu D, et al. Transpl Infect Dis. 2014 Oct;16(5):724-32. doi: 10.1111/tid.12285. Epub 2014 Sep 11. Transpl Infect Dis. 2014. PMID: 25208755 - Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients.
Humar A, St Louis P, Mazzulli T, McGeer A, Lipton J, Messner H, MacDonald KS. Humar A, et al. J Infect Dis. 1999 Feb;179(2):484-8. doi: 10.1086/314602. J Infect Dis. 1999. PMID: 9878035 - Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.
Kidd IM, Clark DA, Sabin CA, Andrew D, Hassan-Walker AF, Sweny P, Griffiths PD, Emery VC. Kidd IM, et al. Transplantation. 2000 Jun 15;69(11):2400-4. doi: 10.1097/00007890-200006150-00032. Transplantation. 2000. PMID: 10868648 - Relationship between beta-herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation.
Chapenko S, Trociukas I, Donina S, Chistyakov M, Sultanova A, Gravelsina S, Lejniece S, Murovska M. Chapenko S, et al. J Med Virol. 2012 Dec;84(12):1953-60. doi: 10.1002/jmv.23412. J Med Virol. 2012. PMID: 23080502
Cited by
- SARS-CoV-2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?
Chen J, Song J, Dai L, Post SR, Qin Z. Chen J, et al. J Med Virol. 2022 Nov;94(11):5103-5111. doi: 10.1002/jmv.27994. Epub 2022 Jul 22. J Med Virol. 2022. PMID: 35819034 Free PMC article. Review. - Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease.
Karaba AH, Figueroa A, Werbel WA, Dioverti MV, Steinke SM, Ray SC, Cox AL, Avery RK. Karaba AH, et al. Transpl Infect Dis. 2021 Aug;23(4):e13682. doi: 10.1111/tid.13682. Epub 2021 Jul 16. Transpl Infect Dis. 2021. PMID: 34216086 Free PMC article. - Novel Strategies to Combat CMV-Related Cardiovascular Disease.
Vasilieva E, Gianella S, Freeman ML. Vasilieva E, et al. Pathog Immun. 2020 Sep 20;5(1):240-274. doi: 10.20411/pai.v5i1.382. eCollection 2020. Pathog Immun. 2020. PMID: 33089035 Free PMC article. Review. - Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance.
Dangi A, Yu S, Lee FT, Burnette M, Wang JJ, Kanwar YS, Zhang ZJ, Abecassis M, Thorp EB, Luo X. Dangi A, et al. Kidney Int. 2020 Jul;98(1):147-158. doi: 10.1016/j.kint.2020.01.034. Epub 2020 Feb 21. Kidney Int. 2020. PMID: 32471635 Free PMC article. - Where do we Stand after Decades of Studying Human Cytomegalovirus?
Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, Biolatti M. Gugliesi F, et al. Microorganisms. 2020 May 8;8(5):685. doi: 10.3390/microorganisms8050685. Microorganisms. 2020. PMID: 32397070 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical